Oruka Therapeutics Inc Sustainability Reports
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel biologics and monoclonal antibodies for the treatment of chronic skin diseases, such as plaque psoriasis.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900TG7O4ESUDMGI54
FIGI: BBG001SB1GL2
No reports are currently available in our catalogue.